Production (Stage)
Adicet Bio, Inc.
ACET
$0.6936
-$0.0251-3.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.21M | -28.73M | -30.48M | -29.90M | -28.02M |
| Total Depreciation and Amortization | 1.68M | 1.62M | 1.59M | 1.60M | 1.65M |
| Total Amortization of Deferred Charges | 15.00K | 0.00 | 0.00 | 0.00 | 39.00K |
| Total Other Non-Cash Items | 2.82M | 3.21M | 7.30M | 6.80M | 6.46M |
| Change in Net Operating Assets | -1.70M | -206.00K | -420.00K | -1.92M | -2.98M |
| Cash from Operations | -25.40M | -24.10M | -22.01M | -23.42M | -22.85M |
| Capital Expenditure | -1.49M | -176.00K | -401.00K | -302.00K | -239.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.37M | -118.12M | -- | -- | -- |
| Cash from Investing | -2.86M | -118.30M | -401.00K | -302.00K | -239.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 96.32M | 0.00 | 204.00K | 111.11M |
| Repurchase of Common Stock | -104.00K | -- | -96.18M | 0.00 | -141.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -104.00K | 96.32M | -96.18M | 204.00K | 110.97M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28.36M | -46.08M | -118.59M | -23.52M | 87.88M |